You've chosen Americas as your location.

To clear your location selection and return to IPS Global, click below.

You've chosen Americas as your location.

Thank you for choosing a location. This will help us show you the information that matters the most to you.

Komal Hatti joins a roundtable discussion on the future of cell and gene therapy production

Roundtable Discussion: Priorities for the Cell and Gene Field

Cell and gene therapy is arguably one of the most exciting sectors of the drug development industry right now. In this roundtable, three experts discuss the turning points for the field so far, the manufacturing challenges, and what can be done to lower the costs of these medicines.

This video features:

Komal Hatti, Director, Process Architect
Tim Lannan, Senior Director, Rare Disease New Product Leader – Launch Excellence, Pfizer Global Supply
Alan Boyd, CEO of Boyds